Palliative Care Symposium for Advanced Practice Providers

June 22, 2019 | USA

This symposium is designed to provide a platform for discussion of relevant and emerging issues in palliative care, including pharmacological management, special populations, research, and complex case discussions. Presentations will include panel discussions, case studies and lectures by leading professionals in the field.The goal is to inform best practices, provide professional empowerment and inspiration, and to further the APP role within and beyond the palliative care specialty.This course will include both primary and specialty palliative care content, appropriate for any RNs, APPs, Social Workers, Chaplains, and/or MDs interested in incorporating palliative care into their practice. The majority of this content will be applicable to any practice setting and not limited to care in the oncology population.

Spotlight

Study objective to determine the effect of elafibranor, a dual PPAR alpha/delta agonist, on fatty acid saturationPhase 2 study to evaluate the effect of a 6-week, once daily treatment of elafibranor (120mg) vs. placebo on hepatic lipid composition in patients with Nonalcoholic Fatty Liver (NAFL)State of the art non invasive techniques (H-MRS) to be used to provide indications on both quantitative and qualitative evolution of liver fat


OTHER PAST CONFERENCES

International Summit on Psychedelic Therapies for Mental Illness, Melbourne

November 17-20, 2021 | Australia

Mind Medicine Australia will hold a two-day International Summit on Psychedelic Therapies for Mental Illness in November 2021 in Melbourne, bringing together clinicians, scientists, academics, mental and public health professionals, philanthropists, investors, Government, law and policy leaders, business, industry, consumers and other interested stakeholders. The event will also feature a two-day pre-Summit introductory workshop program (17-18 November) for anyone with an interest in the topic and who is considering further development of their current therapeutic skills or who are eager to gain a detailed understanding of psychedelic-assisted psychotherapy for the treatment of mental illness.

Investival Showcase

November 8-15, 2021 | UK

Returning for its sixth year, LSX’s Inv€$tival Showcase directly connects life science corporates to global capital and partners. In 2021, Inv€$tival ShowcaseTM is delivered as a hybrid event, blending the best of both virtual and physical! An international showcase of early, growth stage and public life science and health technology companies, Inv€$tival ShowcaseTM provides an unrivalled opportunity to pitch, profile and connect with investors and partners brought together during the biggest fortnight in European life sciences investment. The company showcases will highlight and promote the most exciting and innovative biotech, medtech, health technology and consumer health companies across Europe and beyond. The online experience (8-15th November) features everything from the physical event and more! Hear from, connect, network and schedule 1:1 video meetings with global investors, corporates and strategic partners.

2nd World Mental Health Congress

December 6-7, 2021 | India

Mental Health Congress is an annual flagship event providing best practice updates and truly global outreach. It is a dynamic, innovative, and highly engaging conference that informs its delegates of the latest scientific developments and most importantly helps them to improve the standard of care they deliver on the Wednesday morning after the conference. We now look forward to welcoming you all to the webinar for a global educational and networking event that will present a unique opportunity to learn from each other and to meet with colleagues from all parts of the world. Our International Scientific Committee is not only lining up a diverse and interesting selection of regional and international speakers but also working hard on developing new and improved ways of interaction and education.

PCR London Valves 2021

November 21-23, 2021 | UK

PCR London Valves - a patient-oriented Course for all of the Heart Valve Team. PCRLV is the cross-disciplinary Course for surgical, imaging and interventional heart teams: there were 3,063 active participants at the 2019 edition. The Course provides interactive learning on the 3 valves - aortic, mitral and tricuspid. Looking forward to seeing you in London in 2021.

Spotlight

Study objective to determine the effect of elafibranor, a dual PPAR alpha/delta agonist, on fatty acid saturationPhase 2 study to evaluate the effect of a 6-week, once daily treatment of elafibranor (120mg) vs. placebo on hepatic lipid composition in patients with Nonalcoholic Fatty Liver (NAFL)State of the art non invasive techniques (H-MRS) to be used to provide indications on both quantitative and qualitative evolution of liver fat

resources